Alla Keyzner

524 total citations
34 papers, 277 citations indexed

About

Alla Keyzner is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Alla Keyzner has authored 34 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 13 papers in Genetics and 8 papers in Oncology. Recurrent topics in Alla Keyzner's work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Alla Keyzner is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Alla Keyzner collaborates with scholars based in United States, France and Canada. Alla Keyzner's co-authors include D. H. Schläfer, Vicki N. Meyers-Wallen, Robin Lovell‐Badge, Ian Barr, Sara Kim, John Mascarenhas, Uroosa Ibrahim, Thomas Gerard Bradley, Ruby Sharma and Steven L. Allen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Kidney International.

In The Last Decade

Alla Keyzner

32 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alla Keyzner United States 8 140 88 73 72 66 34 277
Francesco Zinno Italy 11 124 0.9× 47 0.5× 66 0.9× 16 0.2× 85 1.3× 30 247
Alexander Platz Germany 7 156 1.1× 121 1.4× 69 0.9× 63 0.9× 116 1.8× 9 357
Mary Link United States 4 232 1.7× 101 1.1× 309 4.2× 54 0.8× 51 0.8× 8 445
Y. L. Colson United States 10 341 2.4× 62 0.7× 79 1.1× 43 0.6× 308 4.7× 11 573
J Burns United States 7 190 1.4× 53 0.6× 52 0.7× 89 1.2× 125 1.9× 12 323
Kathy Cieply United States 7 58 0.4× 37 0.4× 18 0.2× 141 2.0× 54 0.8× 9 283
Sandra Wymann Switzerland 11 138 1.0× 82 0.9× 24 0.3× 40 0.6× 216 3.3× 20 355
Svetlan Boskovic United States 6 139 1.0× 43 0.5× 32 0.4× 43 0.6× 250 3.8× 6 534
Cristina Castilla‐Llorente France 9 106 0.8× 36 0.4× 35 0.5× 45 0.6× 77 1.2× 40 260
Ahsen Morva France 5 16 0.1× 31 0.4× 48 0.7× 37 0.5× 251 3.8× 9 348

Countries citing papers authored by Alla Keyzner

Since Specialization
Citations

This map shows the geographic impact of Alla Keyzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alla Keyzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alla Keyzner more than expected).

Fields of papers citing papers by Alla Keyzner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alla Keyzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alla Keyzner. The network helps show where Alla Keyzner may publish in the future.

Co-authorship network of co-authors of Alla Keyzner

This figure shows the co-authorship network connecting the top 25 collaborators of Alla Keyzner. A scholar is included among the top collaborators of Alla Keyzner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alla Keyzner. Alla Keyzner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
McCurdy, Shannon R., Scott R. Solomon, Brian C. Shaffer, et al.. (2025). Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation. Transplantation and Cellular Therapy. 32(1). 74.e1–74.e14.
3.
Malki, Monzr M. Al, Alla Keyzner, Hyung C. Suh, et al.. (2024). A phase 1 trial of TSC-100 and TSC-101, engineered T cell therapies that target minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation.. Journal of Clinical Oncology. 42(16_suppl). TPS2678–TPS2678. 1 indexed citations
4.
Jacobs, Samantha E., Uroosa Ibrahim, Usha Govindarajulu, et al.. (2024). Dynamics of cytomegalovirus‐specific T‐cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilot study. Transplant Infectious Disease. 26(3). e14290–e14290. 2 indexed citations
5.
Keyzner, Alla, Jacques Azzi, Rita Jakubowski, et al.. (2023). Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes. Transplantation Proceedings. 55(8). 1799–1809. 2 indexed citations
6.
Ibrahim, Uroosa & Alla Keyzner. (2022). Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation. Hematology Transfusion and Cell Therapy. 45(4). 510–512. 5 indexed citations
7.
Sastow, Dahniel, Jonathan Feld, Michal Bar‐Natan, et al.. (2022). Central Nervous System Specific Characteristics and Outcomes in Acute Myeloid Leukemia Patients with Neurologic Involvement. Blood. 140(Supplement 1). 11618–11620. 1 indexed citations
8.
Kunte, Siddharth, Lisa Rybicki, Auro Viswabandya, et al.. (2021). Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study. Leukemia. 36(3). 856–864. 20 indexed citations
9.
Bijol, Vanesa, et al.. (2021). The Case | Proteinuria in a patient with hematopoietic stem cell transplantation. Kidney International. 99(5). 1249–1250. 2 indexed citations
10.
Ibrahim, Uroosa & Alla Keyzner. (2020). Autoimmune hematologic complications of umbilical cord blood transplantation. Hematology/Oncology and Stem Cell Therapy. 14(2). 104–109. 2 indexed citations
11.
Brody, Joshua, et al.. (2020). Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum. JAAD Case Reports. 6(6). 567–568. 3 indexed citations
12.
Ibrahim, Uroosa, et al.. (2020). Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host. Hematology Transfusion and Cell Therapy. 43(4). 507–511. 1 indexed citations
13.
14.
Coltoff, Alexander, Jane Houldsworth, Alla Keyzner, Anne S. Renteria, & John Mascarenhas. (2018). Role of minimal residual disease in the management of acute myeloid leukemia—a case-based discussion. Annals of Hematology. 97(7). 1155–1167. 8 indexed citations
15.
16.
17.
Keyzner, Alla, Anita D’Souza, Martha Q. Lacy, et al.. (2013). Low Levels of Interleukin-1 Receptor Antagonist (IL-1RA) Predict Engraftment Syndrome after Autologous Stem Cell Transplantation in POEMS Syndrome and Other Plasma Cell Neoplasms. Biology of Blood and Marrow Transplantation. 19(9). 1395–1398. 6 indexed citations
18.
LeBlanc, Amanda J., et al.. (2008). Duplication and triplication of der(21)t(8;21)(q22;q22) in acute myeloid leukemia. Cancer Genetics and Cytogenetics. 188(2). 83–87. 3 indexed citations
19.
Meyers-Wallen, Vicki N., D. H. Schläfer, Ian Barr, Robin Lovell‐Badge, & Alla Keyzner. (1999). Sry-negative XX sex reversal in purebred dogs. Molecular Reproduction and Development. 53(3). 266–273. 65 indexed citations
20.
Meyers-Wallen, Vicki N., et al.. (1999). Sry‐negative XX sex reversal in purebred dogs. Molecular Reproduction and Development. 53(3). 266–273. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Zinno Breakdown of academic impact, for papers by Alexander Platz Breakdown of academic impact, for papers by Mary Link Breakdown of academic impact, for papers by Y. L. Colson Breakdown of academic impact, for papers by J Burns Breakdown of academic impact, for papers by Kathy Cieply Breakdown of academic impact, for papers by Sandra Wymann Breakdown of academic impact, for papers by Svetlan Boskovic Breakdown of academic impact, for papers by Cristina Castilla‐Llorente Breakdown of academic impact, for papers by Ahsen Morva
Rankless by CCL
2026